Innovations in Biologic Therapeutics

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This Genetic Technology TOE depicts trends across biologic therapeutics. With every therapy that is being discovered, there are subsequent discoveries made on the ideal candidates for these therapies. Unfortunately, due to the genetic and cellular variability present in diseases such as cancer, certain therapies are more suitable for a specific strata of patients. The emergence of cell-based therapies and gene therapies will slowly revolutionize personalized therapeutics across diseases that are difficult to treat. The corresponding patent scenario is depicted, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with

Table of Contents

Innovations in Biologic TherapeuticsInnovation ProfilesChimeric Antigen Receptor T Cell Therapy for Haematological MalignanciesMolecular Switches for CAR-based T Cell TherapiesComputational Immunology Techniques Aid in Vaccine Development Platform Technologies for Better Next Gen Biologic Therapeutics Stem Cell TrendsIndustry Contacts




Keyword1

Keyword2

Keyword3

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.